Research partially funded by the JKTG Foundation recently appeared recently in the Bulletin of Mathematical Biology.
The research, Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer, includes work by Heiko Enderling, Ph.D., a researcher with whom JKTG has worked on several projects.
As described in the published abstract, first-line therapy for prostate cancer includes androgen deprivation therapy (ADT), depriving both the normal and malignant prostate cells of androgens required for proliferation and survival.
In recent years, intermittent ADT has been proposed as an alternative to continuous ADT. Several mathematical models with different biological resistance mechanisms have been considered to simulate intermittent ADT response dynamics.
The research compares 13 intermittent dynamical models and assess their ability to describe prostate-specific antigen (PSA) dynamics.
Featured news
Ted’s Take: Leaders and Leadership
We need more leaders; Government, businesses, consulting firms, fortune 500 companies, associations, you name it. The problem is there is a dearth of leaders, but few are truly able to take a leadership role.
Ted’s Take: Do we need AI guardrails?
Artificial Intelligence (AI) is all the rage now. There are all numbers of folks developing AI technology and applications that range from simple to complex.
Ted’s Take: Does AI learn and incorporate our biases?
We hear tons of conversation around the use of Artificial Intelligence (AI). We also hear that the application of AI might be the solution to almost everything. While that’s both an overstatement and unrealistic, there are a lot of companies and folks working to make AI do just that — solve everything
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133